Posted by Michael Wonder on 16 Sep 2025
AbbVie's Vraylar (cariprazine) now publicly reimbursed in Alberta
15 September 2025 - AbbVie announced today that Alberta has listed Vraylar (cariprazine) on its Health Drug Formulary.
Vraylar is already listed in all provinces and by federal programs including Non-Insured Health Benefits, Correctional Service Canada and Veterans Affairs Canada for the treatment of schizophrenia.
